Abstract: A medical information processing system according to an embodiment includes processing circuitry and a display. On the basis of one of the type of at least one abnormality detection algorithm to which a medical image related to an examined subject is to be input and information relevant to an abnormality detected by inputting the medical image to the abnormality detection algorithm, the processing circuitry judges whether or not urgency is present in a disorder related to the abnormality. When it is determined that the urgency is present, the display displays, in an examination list of examination orders, assessment information related to assessing the abnormality and urgency information indicating the urgency so as to be positioned adjacent to any of the examination orders related to the abnormality.

Abstract: An information processing device of the present invention is capable of collaboration with a learning device to determine whether an image group that has been obtained in time series by the first endoscope is an image group obtained at a first time or at a second time, and to create a first inference model for image feature determination of images for the first endoscope by performing learning with results of having performed annotation on the image group that was obtained at the second time as training data, the information processing device comprising at least one or a plurality of classifying processors that classify image groups constituting training data candidates, within an image group from the first endoscope that has been newly acquired, or an image group from a second endoscope, using the image group that has been obtained at the first time, when the first inference model was created.

Abstract: A fire retardant material comprising a carbon fiber which tensile elasticity is 700 GPa or more, and a fire retardant resin such as polycarbonate.

Abstract: The present invention provides an approach to enhancing the production of a foreign protein serving as a protein-based pharmaceutical product in host cells such as cultured cells derived from a mammal. The present invention provides transformed cells having a novel Hspa5 gene promoter, and a method for secreting and producing a foreign protein at high levels using the transformed host cells.

Abstract: The present invention provides an approach to enhancing the production of a foreign protein serving as a protein-based pharmaceutical product in host cells such as cultured cells derived from a mammal. The present invention provides transformed cells having a novel Hspa5 gene promoter, and a method for secreting and producing a foreign protein at high levels using the transformed host cells.

Abstract: The present invention provides an approach to enhancing the production of a foreign protein serving as a protein-based pharmaceutical product in host cells such as cultured cells derived from a mammal. The present invention provides transfected cells having a novel Hspa8 gene promoter, and a method for secreting and producing a foreign protein at high levels using the transfected cells.

Abstract: The present invention provides an approach to enhancing the production of a foreign protein serving as a protein-based pharmaceutical product in host cells such as cultured cells derived from a mammal. The present invention provides transformed cells having a novel Hspa5 gene promoter, and a method for secreting and producing a foreign protein at high levels using the transformed host cells.

Abstract: The object of the present invention is to provide a production system that is capable of high-level secretory production of a protein (and in particular, a protein with a complicated structure such as a structure with S—S bonds) in a host cell such as yeast and is suitable for industrial production with high safety that does not require explosion-proof facilities. The present invention provides a transformed yeast into which a chaperone gene has been introduced and in which the aox1 gene and/or the protease gene have been disrupted and a method for producing a protein involving the use of such transformed yeast.

Abstract: This invention provides a means for high-level secretory production of a protein, and, in particular, a protein having a complicated structure such as an antibody, in a host cell such as a yeast cell. This invention provides a method for high-level secretory production of a foreign protein with the use of a transformed host cell having one or more types of chaperone protein genes and via suppression of O sugar chain inherent to a host cell such as a yeast cell.

Abstract: This invention provides a means for enabling high-level secretory production of proteins, in particular proteins having complicated structures such as antibodies, in host cells such as yeast cells. The invention also provides transformed yeast cells having the activated HAC1 gene and the RRBP1 gene and a method for enabling high-level secretory production of foreign proteins using such transformed host cells by inhibiting O-sugar chain formation indigenous to host cells such as yeast cells.

Abstract: A data processing device is provided enabling faster read access to data in an on-chip EEPROM with relative ease, without increasing the area occupied by the chip and its power consumption. The on-chip nonvolatile memory included in the data processing device is provided with a pre-read cache which latches all or part of data, once having been read to bit lines from an array of nonvolatile memory cells by selecting a row address, and a selecting circuit which selects a portion of the data latched by the pre-read cache by selecting a portion of columns. Control is performed to retain address information for data latched by the pre-read cache, inhibit latching new data into the pre-read cache for read access to data in the nonvolatile memory according to the same address as the retained address information, and cause the selecting circuit to select the data latched by the pre-read cache.

Abstract: This invention provides a means for high-level secretory production of a protein, and, in particular, a protein having a complicated structure such as an antibody, in a host cell such as a yeast cell. This invention provides a method for high-level secretory production of a foreign protein with the use of a transformed host cell having one or more types of chaperone protein genes and via suppression of O sugar chain inherent to a host cell such as a yeast cell.

Abstract: This invention provides a means for enabling high-level secretory production of proteins, in particular proteins having complicated structures such as antibodies, in host cells such as yeast cells. The invention also provides transformed yeast cells having the activated HAC1 gene and the RRBP1 gene and a method for enabling high-level secretory production of foreign proteins using such transformed host cells by inhibiting O-sugar chain formation indigenous to host cells such as yeast cells.